Login / Signup

Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies.

Nikolai MühlbergerGaby SroczynskiArtemisa GogollariBeate JahnNora PashayanEwout SteyerbergMartin WidschwendterUwe Siebert
Published in: The European journal of health economics : HEPAC : health economics in prevention and care (2021)
Economic models suggest that breast cancer screening and prevention are cost effective in the European setting. All screening models predict gains in life expectancy, which has not yet been confirmed by trials. European models evaluating risk-adapted screening strategies are rare, but suggest that risk-adapted screening is more effective and efficient than conventional screening.
Keyphrases
  • young adults